Manufacturer record
Regain Laboratories 134/5: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Regain Laboratories 134/5 (Chhattisgarh) were declared Not of Standard Quality between September 2024 and August 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: IGMK445, Gentamicin Injection IP (Gentatore Injection) (exp Oct 2026). CDL, Kolkata (CDSCO lab) found it not of standard quality: Particulate matter and Description. Listed in the August 2025 alert.
Records by type
2 records linked to Regain Laboratories 134/5 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Gentamicin Injection IP (Gentatore Injection) | Batch IGMK445Mfg Nov 2024 · Exp Oct 2026 | Particulate matter and DescriptionDescription | CDL, KolkataCDSCO lab | Aug 2025 |
| Gentamicin Injection I.P. (Gentagain) | Batch IGMJ330Mfg Oct 2023 · Exp Sep 2025 | Description & Particulate matterDescription | CDL KolkataCDSCO lab | Sep 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.